News
June 4, 2025
June 4, 2025
(Amsterdam, Europe), — June 1st 2025 — Liberi Group and Starodub B.V. are pleased to announce the signing of an agreement to provide mutual referral consultancy services, effective May 1, 2025. This strategic collaboration reflects both organizations’ commitment to delivering world-class expertise and innovation in the life sciences and the professional services sectors.
Under the terms of the agreement, Liberi Group and Starodub B.V. will work closely together to leverage their combined knowledge, networks, and operational strengths, foster enhanced value creation for clients and stakeholders across both organizations.
“We are delighted to formalize our relationship with Starodub B.V. through this consultancy agreement,” said Frans Trouwen, Founder, CEO and Chairman of the Board of Liberi Group. “This partnership marks a significant milestone in our growth strategy, enabling us to broaden our reach and enhance the quality of services we offer.”
Valentyna Starodub, CEO of Starodub B.V., commented: “Our collaboration with the Liberi Group represents a powerful alignment of complementary strengths. While Liberi brings global expertise in business development, valuation, and investment services, Starodub adds deep regulatory, quality, manufacturing and product development know-how across pharmaceuticals and medical devices. Together, we offer biotech companies a uniquely integrated pathway— from early development and regulatory strategy to global market access and investor readiness.”
The agreement will initially focus on joint referral consultancy initiatives across the global life sciences field whereas Liberi Group will provide the Business Development Services and Valuation Services and Starodub B.V, will provide the Regulatory, Quality and Manufacturing Services, with future opportunities for expanded collaboration already under discussion.
About Liberi Group
Liberi Group is a global Life Sciences Consultancy Firm with subsidiaries in both Europe and South Korea providing Business Development Services, Valuation Services and Investment Search for biotech companies.
About Starodub B.V.
Starodub B.V. is a consultancy guiding the development and approval of medicines and medical devices. Our experts support regulatory, quality, and manufacturing activities across small molecules, biologics, ATMPs, vaccines, devices, and software.
For media inquiries, please contact:
Frans Trouwen, Founder, CEO and Chairman of the Board of Liberi Group, [email protected]
Valentyna Starodub, founder and CEO of Starodub,
[email protected]